Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Motixafortide + Imatinib in CML
NCT02115672Phase 2Withdrawn
- Sponsor
- Sheba Medical Center
- Start
- Nov 2014
- Primary completion
- Nov 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of motixafortide in chronic myeloid leukemia (CML), sponsored by Sheba Medical Center. Planned start Nov 2014; status: withdrawn.
02
Drugs
motixafortide
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02115672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02115672.